Wire flash
Insilico Medicine (03696.HK) announces multi-million-dollar AI collaboration with frontier foundation model lab
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Insilico Medicine (stock code: 03696) announced a collaboration with a frontier foundation model lab, with a contract value potentially reaching tens of millions of dollars. Under the agreement, the two parties will leverage the MMAI Gym training framework to jointly develop, validate, and commercialize a series of cutting-edge foundation models specifically designed for biological research. Insilico Medicine will provide proprietary datasets covering multiple specialized life science tasks and conduct closed-loop wet-lab validation of the models' outputs during training. The partnership includes a revenue-sharing model, with both sides utilizing their respective partner networks in the biomedical field to drive global commercialization. The announcement was made via a filing to the Hong Kong Stock Exchange and reported by Zhitong Finance.
Source report
Hong Kong, [Date] – Insilico Medicine (03696.HK) has announced a collaboration with a leading frontier foundation model laboratory, with a total contract value reaching up to several tens of millions of U.S. dollars.
Collaboration Details
Under the agreement, both parties will leverage the MMAI Gym training framework to jointly develop, validate, and commercialize a series of cutting-edge foundation models specifically designed for biological research.
Key Terms of the Agreement
- Deep Integration of Expertise: The partners will combine their respective strengths to build specialized foundation models for generative biology.
- Proprietary Datasets: Insilico Medicine will provide proprietary datasets covering a range of specialized life science tasks.
- Closed-Loop Wet-Lab Validation: The company will conduct closed-loop wet-lab validation on results generated during the foundation model training process.
- Revenue Sharing Model: A revenue-sharing structure has been established to support global commercialization through each party's respective partner networks in the biomedical field.
Source
智通财经Eastern
Part of this Story
Insilico Medicine signs multi-million dollar AI partnership to build biology foundation models